Förderreuther, Stefanie
Zhang, Qi
Stauffer, Virginia L.
Aurora, Sheena K.
Láinez, Miguel J. A.
Funding for this research was provided by:
Eli Lilly and Company (None)
Article History
Received: 16 October 2018
Accepted: 10 December 2018
First Online: 29 December 2018
Ethics approval and consent to participate
: The study protocols were reviewed and approved by the appropriate institutional review board for each of the study sites. The studies were conducted according to Good Clinical Practice and the Declaration of Helsinki guidelines. Patients provided written informed consent before undergoing study procedures.
: Not applicable.
: Stefanie Förderreuther, MD Steffi.Foerderreuther@med.uni-muenchen.deLudwig-Maximilians-University of Munich, Department of Neurology<i>Speaker’s Bureau</i>: Novartis, Sanofi<i>Consultation</i>: Sanofi<i>Honoraria</i>: Allergan, Hormosan Pharma, AstraZeneca<i>Advisory Boards</i>: Novartis, Eli LillyQi Zhang, PhD qi.zhang@sanofi.comEmployee of Sanofi, Bridgewater, NJ, USAFormer employee of Eli Lilly and Company, and/or one of its subsidiaries, Indianapolis, IN, USAVirginia L. Stauffer, PharmD vstauffer@lilly.comEmployee of Eli Lilly and Company, and/or one of its subsidiaries, Indianapolis, IN, USASheena K. Aurora, MD sheena.aurora@lilly.comEmployee of Eli Lilly and Company, and/or one of its subsidiaries, Indianapolis, IN, USAMiguel JA Láinez, MD, PhD miguel.lainez@sen.esHospital Clínico Universitario, Universidad Católica de Valencia, Spain<i>Research Grants</i>: Allergan, Amgen, ATI, Bayer, Boehringer, electroCore, Eli Lilly, Medtronic, Novartis, Otsuka, Roche, Teva and UCB<i>Consultation</i>: Allergan, Amgen, ATI, Bayer, Boehringer, electroCore, Eli Lilly, Medtronic, Novartis, Otsuka, Roche, Teva and UCB<i>Honoraria</i>: Allergan, Amgen, ATI, Bayer, Boehringer, electroCore, Eli Lilly, Medtronic, Novartis, Otsuka, Roche, Teva and UCB
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.